We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
+16.06%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$339M
(-53%)
Cap. Flow
-$372M
Cap. Flow
% of AUM
-124.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$372M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $181M | 60.57% |
2,111,111
| – | – |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $99.5M | 33.33% |
9,166,667
| – | – |
|
3
Cytokinetics
CYTK
$11.5B
| $18.2M | 6.09% |
875,656
| – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $26K | 0.01% |
37,005
| – | – |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| – | – |
-4,373,178
| Closed | -$372M |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC